Guideline issued on molecular biomarkers for CRC tissues

(HealthDay)—A guideline, published online Feb. 6 in the Archives of Pathology & Laboratory Medicine, has been developed in relation to molecular biomarker testing of colorectal cancer (CRC) tissues.

Better mouse model enables colon cancer research

Every day, it seems, someone in some lab is "curing cancer." Well, it's easy to kill cancer cells in a lab, but in a human, it's a lot more complicated, which is why nearly all cancer drugs fail clinical trials.

page 1 from 2

Colorectal cancer

Colorectal cancer, also called colon cancer or large bowel cancer, includes cancerous growths in the colon, rectum and appendix. With 655,000 deaths worldwide per year, it is the third most common form of cancer and the second leading cause of cancer-related death in the Western world. Many colorectal cancers are thought to arise from adenomatous polyps in the colon. These mushroom-shaped growths are usually benign, but some may develop into cancer over time. The majority of the time, the diagnosis of localized colon cancer is through colonoscopy. Therapy is usually through surgery, which in many cases is followed by chemotherapy.

This text uses material from Wikipedia, licensed under CC BY-SA